When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
PRNB - Dosing underway in Sanofi's late-stage SAR442168 trial in relapsing multiple sclerosis
Principia Biopharma Inc.
The first patient has been enrolled in Sanofi’s (NASDAQ:SNY) Phase 3 clinical trial of partner Principia Biopharma's (NASDAQ:PRNB) SAR442168 in patients with relapsing multiple sclerosis.
More news on: Sanofi, Principia Biopharma Inc., Healthcare stocks news,